M&As this week: The Straumann Group, Molnlycke Health Care, Young Innovations

6 July 2018 (Last Updated November 22nd, 2018 11:23)

The Straumann Group has purchased a 30% interest in its biomaterials partner Botiss Medical for an undisclosed sum.

The Straumann Group has purchased a 30% interest in its biomaterials partner Botiss Medical for an undisclosed sum.

Based in Switzerland, Straumann is a replacement and orthodontic solutions provider, while Botiss Medical is a Germany-based provider of biomaterials for implantology and oral surgery.

The transaction enables the acquirer to expand its worldwide distribution network through Botiss’ line of products.

Molnlycke Health Care has completed the acquisition of SastoMed for an undisclosed sum.

Based in Sweden, Molnlycke Health Care is a medical device company that provides wound care products, while SastoMed is also a wound care products provider based in Germany.

The transaction enables the acquirer company to strengthen its position in the active and passive wound healing areas.

“The acquisition will be a complementary addition to Thermo Fisher’s electron microscopy portfolio and enhances its product offerings.”

Young Innovations has completed the acquisition of Johnson-Promident, a US-based producer and retailer of dental hand-pieces and preventive consumables.

The transaction enables the acquirer to support its dealers, institutional partners and dental professionals across the world by delivering high-quality products.

Based in the US, Young Innovations is a medical device company that provides dental products and a portfolio company of The Jordan Company.

Shanghai Kehua Bio-engineering plans to purchase 26.6983% capital in Suzhou Hybiome Biomedical Engineering Co Ltd for CNY336.02m ($50.7m).

Both the companies involved in the transaction are medical device companies based in the US.

Thermo Fisher has signed an agreement to purchase Roper subsidiary Gatan for $925m.

The acquisition is expected to close in the last quarter of 2018, subject to customary closing conditions and other regulatory approvals.

Thermo Fisher is a provider of diagnostic products, while Gatan is a manufacturer of instrumentation and software. Both companies are based in the US.

The acquisition will be a complementary addition to Thermo Fisher’s electron microscopy portfolio and enhances its product offerings.